MrTAC-8
MrTAC-8, methylarginine-targeting chimera (MrTAC), is a BRD4 degrader with DC50 values of 46 nM in HeLa cells. MrTAC-8 recruits PRMT1, PRMT3, PRMT4, PRMT5, and PRMT7 to target proteins, inducing arginine methylation that triggers lysosomal degradation. MrTAC-8 degrades proteins across diverse subcellular localizations and independent of native proteolytic routes. MrTAC-8 can be used for the research of cervical cancer, glioblastoma.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C54H65ClN10O6S
- Peso molecular:1017.68
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
BRD4 |
MrTAC-8 (0.01 nM-10 μM; 24 h) potently induces lysosomal degradation of endogenous BRD4 via catalytically active PRMT5 recruitment, with DC50 values of 46 nM in HeLa cells, 67 nM in U87 cells, and 4.8 μM in HEK293 cells[1].
MrTAC-8 (1 μM; 2 h) blocks BRD4 degradation in HeLa cells when pre-treated with lysosomal inhibitors bafilomycin and Chloroquine (HY-17589A), restoring BRD4 levels to 110% of DMSO control[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293, HeLa, U87 human cancer cells
-
Concentration:0.01 nM; 0.1 nM; 1 nM; 10 nM; 100 nM; 1 μM; 10 μM
-
Incubation Time:24 h
-
Result:Reduced BRD4 levels to 39% of DMSO control in HEK293 cells at 1 μM.
Reduced BRD4 levels to 13% of DMSO control in HEK293 cells at 10 μM.
Demonstrated cell line-specific potency, with DC50 values of 46 nM in HeLa cells, 67 nM in U87 cells, and 4.8 μM in HEK293 cells.
-
Cell Line:HeLa human cervical cancer cells
-
Concentration:1 μM plus 500 nM bafilomycin and 10 μM Chloroquine
-
Incubation Time:2 h
-
Result:Blocked BRD4 degradation when pre-treated with lysosomal inhibitors bafilomycin and Chloroquine, restoring BRD4 levels to 110% of DMSO control.
Reduced BRD4 levels to 100% of DMSO control in cells expressing catalytically dead (E444Q) PRMT5 at 1 μM, compared to 15% reduction in cells expressing wild-type PRMT5.
Enriched BRD4 in SDMA-positive fractions after treatment, confirming proximity-induced arginine methylation.
Chemical Information
-
Peso molecular 1017.68
-
Fòrmula C54H65ClN10O6S
-
SMILES
O=C(NCCC1CCN(CC(C(NCCOCCNC(C[C@@H]2N=C(C3=CC=C(Cl)C=C3)C4=C(SC(C)=C4C)N5C(C)=NN=C25)=O)=O)=C)CC1)C6=CC=C(C(NC[C@H](O)CN7CCC8=CC=CC=C8C7)=O)C=C6
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MrTAC-8 Related Classifications
HY-183061 Related Classifications
Powered by Bioz